Roche Media 3. Juni 2026 Roche’s giredestrant secures FDA priority review for breast cancer - Pharmaceutical Technology
Roche Media 2. Juni 2026 ASCO: Roche, head held high, details oral SERD's first-line flop in breast cancer - Fierce Biotech
Roche Media 29. Mai 2026 AstraZeneca, Roche to boost digital pathology uptake in APAC and more briefs - Healthcare IT News
Roche Media 21. Mai 2026 Roche Appointed NP15 Medical Director at Yale New Haven Hospital - Yale School of Medicine
Roche Media 15. Mai 2026 Roche's ctDNA-guided approach in post-surgical bladder cancer pays off with Tecentriq nod - Fierce Pharma
Roche Media 7. Mai 2026 Roche shells out up to $1B for PathAI in move to boost artificial intelligence-powered diagnostics - Fierce Biotech
Roche Media 6. Mai 2026 Roche Korea, KHIDI and Basel partners launch open innovation alliance for Korean biotechs - koreabiomed.com
Roche Media 23. Apr. 2026 Roche Q1 earnings suffer blood bath, but currency headwinds aren’t the only culprit - Fierce Pharma
Roche Media 23. Apr. 2026 From debt to ‘acceptable’ prices: Roche CEO lists 3 reasons for sitting out Big Pharma M&A spree - Fierce Biotech
Roche Media 22. Apr. 2026 The latest biotech news: RevMed, Roche, Kyverna CAR-T therapy - statnews.com
Roche Media 21. Apr. 2026 With successful trials, Roche takes its MS drug to regulators, but safety questions loom - statnews.com
Roche Media 21. Apr. 2026 Roche unpacks death imbalance, secondary endpoints in phase 3 multiple sclerosis trials - Fierce Biotech